Identification of a novel frameshift mutation (L345Sfs*15) in a Korean neonate with methylmalonic acidemia
Author(s) -
Young A Kim,
Jiyong Kim,
YooMi Kim,
Chong Kun Cheon
Publication year - 2017
Publication title -
journal of genetic medicine
Language(s) - English
Resource type - Journals
eISSN - 2233-9108
pISSN - 1226-1769
DOI - 10.5734/jgm.2017.14.2.80
Subject(s) - methylmalonic acidemia , methylmalonic acid , lethargy , compound heterozygosity , frameshift mutation , cardiomyopathy , medicine , methylmalonic aciduria , exon , newborn screening , endocrinology , chemistry , mutation , gastroenterology , biochemistry , heart failure , gene , vitamin b12
indicates complete deficiency, and mut, which indicates partial deficiency [4]. MMA has been associated with various clinical phenotypes ranging from a benign condition to fatal neonatal disease [5]. Patients with mut often present ketoacidosis, lethargy, repeated vomiting, coma or even death, in the newborn period, and suffer from severe long-term complications such as renal failure and neurological impairments. On the other hand, patients with mut have a lower occurrence of mortality, morbidity, and long-term complications [5]. Cardiac disease is a known, yet rare, lethal complication of MMA [6,7] and it has been scarcely reported in the Asian population [7]. We report herein a novel MUT gene mutation in a Korean newborn with Identification of a novel frameshift mutation (L345Sfs*15) in a Korean neonate with methylmalonic acidemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom